These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34461614)

  • 1. Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches.
    Balzerano A; Paccosi E; Proietti-De-Santis L
    Cytogenet Genome Res; 2021; 161(6-7):362-371. PubMed ID: 34461614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing of cancer genomes: lessons learned.
    Corrigan AE; Taylor R; Rallis KS
    Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
    [No Abstract]   [Full Text] [Related]  

  • 4. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
    Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
    Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing-based gene panel tests for the management of solid tumors.
    Nagahashi M; Shimada Y; Ichikawa H; Kameyama H; Takabe K; Okuda S; Wakai T
    Cancer Sci; 2019 Jan; 110(1):6-15. PubMed ID: 30338623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future molecular profiling of cancer by next-generation sequencing.
    Shibata T
    Jpn J Clin Oncol; 2015 Oct; 45(10):895-9. PubMed ID: 26292697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling in oncology clinical practice.
    Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
    Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Cancer Research and Medicine with Single-Cell Genomics.
    Lim B; Lin Y; Navin N
    Cancer Cell; 2020 Apr; 37(4):456-470. PubMed ID: 32289270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine for cancer with next-generation functional diagnostics.
    Friedman AA; Letai A; Fisher DE; Flaherty KT
    Nat Rev Cancer; 2015 Dec; 15(12):747-56. PubMed ID: 26536825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.
    Schwaederle M; Daniels GA; Piccioni DE; Fanta PT; Schwab RB; Shimabukuro KA; Parker BA; Kurzrock R
    Mol Cancer Ther; 2015 Jun; 14(6):1488-94. PubMed ID: 25852059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances for studying clonal evolution in cancer.
    Ding L; Raphael BJ; Chen F; Wendl MC
    Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.